Navigation Links
Neuroscientist Michael Gazzaniga awarded Humboldt Prize
Date:6/26/2008

(Santa Barbara, Calif.) Michael Gazzaniga, professor of psychology at UC Santa Barbara and director of the SAGE Center for the Study of the Mind, has received the Humboldt Research Prize in recognition of lifetime achievements in science.

"Professor Gazzaniga is a true pioneer in reaching across the disciplines to answer fundamental human questions about the relationship between mind and brain," said UCSB Chancellor Henry T. Yang. "The Humboldt Research Prize is a prestigious award and peer recognition that honors not only his lifetime achievements and discoveries, but also the far-reaching impact of his sustained contributions as the founder of the cognitive neuroscience field."

The Alexander von Humboldt Foundation of Germany grants up to 100 Humboldt Research Awards annually to scientists and scholars "whose fundamental discoveries, new theories, or insights have had a significant impact on their own discipline and who are expected to continue producing cutting-edge achievements in the future." Winners receive 60,000 Euros (approximately $93,000) and are invited to conduct research at an institution of their choice in Germany.

At UCSB, Gazzaniga oversees an extensive and broad research program investigating how the brain enables the mind. Over the course of several decades, a major focus of his research has been a study of patients that have undergone split-brain surgery that has revealed lateralization of functions across the cerebral hemispheres.

Gazzaniga is also principal investigator of the Law and Neuroscience Project, the first systematic effort to bridge the fields of law and science in considering how courts should deal with new brain-scanning techniques as they apply to matters of law. The project is a multi-institution effort funded by an initial, three-year, $10-million grant from the John D. and Catherine T. MacArthur Foundation.

He is also director of the Summer Institute in Cognitive Neuroscie
'/>"/>

Contact: Eileen Conrad
eileen.conrad@ia.ucsb.edu
805-893-8726
University of California - Santa Barbara
Source:Eurekalert

Page: 1 2

Related biology news :

1. Advertisers, neuroscientists trace source of emotions in brain
2. Michael A. Betts, Seasoned Financial Services Executive, Joins CIC Board of Directors
3. American Society for Microbiology honors Michael Bruce Zwick
4. Michael A. Betts, Seasoned Financial Services Executive, Joins CIC Board of Directors
5. Remarks Prepared for Delivery By Attorney General Michael B. Mukasey At the Ministerial Press Conference
6. 12 McGill researchers awarded Canada Research Chairs
7. Anthony S. Fauci awarded Lasker Award for Public Service
8. ETH Zurich professor Ari Helenius awarded Benoist Prize
9. Nanobiosym awarded $2 million DTRA contract
10. Mustafa alAbsi Ph.D. and national team awarded major NIH grant
11. Parus Interactive Awarded Patent for Speech-Activated Remote System Management

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Stents that keep weakened and flabby arteries fr...r six months, those stents are no longer needed --...nnecessary. Previously, doctors had no choice but ... of Tel Aviv University,s Department of Biomedical...ber platform that carries drugs where they,re need...
(Date:11/24/2009)... Springer and the American College of Medical Tox...rate on the publication of the Journal of Medical...MT, beginning in March 2010. It was previously pu..., The Journal of Medical Toxicology , an intern...vancing the science and practice of medical toxico...
(Date:11/24/2009)..., BATON ROUGE Antarctica has long held secrets ...nd until recently, there has been very little info...beneath miles of ice for millions of years. Now, a...ding LSU have been funded to the tune of $10 mill... NSF, to get to the bottom of things literally. T...
Breaking Biology News(10 mins):A coating for life 2Springer and the American College of Medical Toxicology to work together 2LSU gets to the bottom of things -- in Antarctica 2Endologix Announces Live Web Cast of Presentation in SMH Capital Small Cap Spotlight on June 17 2009 at 4 3A15 p m ET 48957 1Endologix Announces Live Web Cast of Presentation in SMH Capital Small Cap Spotlight on June 17 2009 at 4 3A15 p m ET 48957 2Psoriasis Raises Risk of Heart Attack Stroke Death 48954 1Psoriasis Raises Risk of Heart Attack Stroke Death 48954 2MUHC researcher awarded 24500 000 to study pathogenesis of infectious disease 48951 1MUHC researcher awarded 24500 000 to study pathogenesis of infectious disease 48951 2
... that moonlight, having different roles at differe... being killed. The moonlighting activity of one en...ially resistant to a family of broad-spectrum anti...tember issue of the journal Microbiology. , "G...eria use to make the building blocks of cell walls...
...y recent reports documenting the therapeutic effic...odels of human disease may actually be describing ...ility of siRNA to activate an immune response, acc...ume 19, Number 9) of Human Gene Therapy , a peer-...c. The paper, which was published "instant online,...
...ncerned about the toll that mental health disorder...l have a unique opportunity to hear from world-cla...es, symptoms and progression of such illnesses as ...ia and autism, and learn about current and potenti... Healthy Minds Across America, 48 free public foru...
Other Biology News:Energy-saving bacteria resist antibiotics 2Previous claims of siRNA therapeutic effects called into question by report in human gene therapy 2Healthy Minds Across America features 48 public forums on mental health research, Sept. 14 2Healthy Minds Across America features 48 public forums on mental health research, Sept. 14 3
(Date:11/25/2009)..., BOSTON,Nov.25/PRNewswire/--BiotechfirmReplikins...he1918pandemicthroughtheprediction,outbreak,andpro...biochemicalanalysisofthevirus.Thenewdatashowsthatt...mitspeakof3.7(s.d.4.5)duringthevirus,scurrentoutbr...sweekof2.0(s.d.0.1).TheH1N1virus,infectivitycount,...
(Date:11/25/2009)..., BEIJING,Nov.25/PRNewswire-Asia/--SinovacBiotech...announcedtodaythatitexecuted,ajointventure(JV)agre...o.,Ltd.(SinovacDalian).TheJVwillresearch,develop,p...llcontributeitsexpertise,andexperienceindeveloping...tywillbringitslanduserights,manufacturingfacilitie...
(Date:11/24/2009)..., HOUSTON,Nov.24/PRNewswire-FirstCall/--IES(Nasda...ommunicationssystemsandservicesforthecommercial,in...scommercialbusinessgrouphasbeenawardedacontractfro...theLevel4bio-safetylab(BSL-4)replacementfacilityat...eases(USAMRIID)atFortDetrickinFrederick,Md. ,, ...
(Date:11/24/2009)..., CALGARYandBLENHEIM,Ontario,Nov.24/PRNewswire-Fi...cquiringtheassetsofHylandSeeds,adivisionofThompson...swillfurtherexpandDowAgroSciences,currentseedsbusi...Stax(TM) in 2010 andDowAgroSciencesHerbicideTole...oseisexpectedinthenearfuture. ,, "Thisacquisiti...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...ented at the AACR,meeting in San Diego efficacy an... for ovarian cancer. FAS31 is an inhibitor of fatt...xpressed in many human cancers. Numerous,studies h...ytotoxic to a,variety of human xenograft models wi...AS31 showed no observable toxicity in normal tissu...
...asdaq:,EVVV) will release its 2008 first quarter f...gular market trading hours., The company will hos...30 a.m. CT (8:30 a.m. ET). ev3 management will rev... outlook, followed by a question and answer,sessio...rested parties through a,live audio webcast at ht...
...BCI), a,biopharmaceutical company utilizing its pl...s that promote the growth of new neurons for the t... announced today that it raised an,additional $20 ... bringing,the total to $50 million. New investor, ... investors and Alexandria Real Estate Equities, In...
Other Biology Technology:FASgen, Inc. Presents Ovarian Cancer Efficacy and Toxicology Data to the American Association for Cancer Research 2REVISED: BrainCells Inc. Expands Series B Financing to $50 Million 2
Mouse Anti-Human RDH5 Polyclonal Antibody, Unconjugated from Abnova Corporation
...Lines ,High Quality, Functionally-Validated, Ion C...or having a critical role in nerve and muscle func... CNS and the heart. Drugs that modulate ion channe...ch as neuropathic pain, cardiac arrhythmia, hypert...
The Discovery Series PDQuest Version Upgrade from Bio-Rad
Mouse Anti-Human ARHGEF11 Monoclonal Antibody, Unconjugated, Clone 2F4 from Abnova Corporation
Biology Products: